europa development group, inc.

100 merrick road
suite 340w
rockville centre, new york 11570

NYS Entity Status
ACTIVE

NYS Filing Date
JULY 16, 2014

NYS DOS ID#
4607154

County
NASSAU

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC BUSINESS CORPORATION

Name History
2014 - EUROPA DEVELOPMENT GROUP, INC.









Buffer

submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • High schoolers warned not to protest national anthem
    By Mark Moore - Thursday Sep 28, 2017

    The Diocese of Rockville Centre warned their three high schools on Long Island that students or fans kneeling or protesting during the national anthem before games or other school events could face? “serious disciplinary action.” ?“This is a reminder that all student-athletes and spectators are expected to stand during the playing of the National Anthem...

    Source: New York Post: Sports
  • IAB Tech Lab Launches Blockchain Working Group
    Monday Sep 18, 2017

    GroupM, Kochava, MetaX, and Nyiax have become member companies in an IAB Tech Lab working group that launched Monday focused on blockchain and explore ways to use it in digital technology. ShailleySingh leads the group. The working group will initially design ways to educate the industry, set priorities for business use cases and develop standards and best practices. 

    Source: Media Post: Search Marketing Daily
  • Solar Developers and Panel Makers Clash Over Tariff Request
    By DIANE CARDWELL - Tuesday Aug 15, 2017

    Troubled domestic manufacturers say cheap Chinese products have undercut their own, but industry groups are urging a trade panel to reject sanctions.

    Source: NYT > Home Page
  • Aimmune in Brisbane teams with Regeneron to find peanut allergy cure
    By Caroline Chen - Tuesday Oct 17, 2017

    Aimmune Therapeutics Inc. is teaming with Regeneron Pharmaceuticals Inc. in hopes of developing a cure for peanut allergies. Aimmune, based in Brisbane, specializes in food allergy treatments and has been developing a desensitizing therapy, AR101, to protect peanut allergy sufferers against reactions from accidental exposures. By combining AR101 with Regeneron’s inflammation-inhibiting drug Dupixent, the companies are seeking to increase protection enough so patients stop reacting to peanuts even after treatment ends. “What we’re learning is that the immune system does seem to be plastic, and with the right group, you can turn the disease back,” Aimmune’s chief executive officer, Stephen Dilly, said.

    Source: SFGATE.com: Business and Technology News
  • Europa’s future: A runaway greenhouse
    By John Timmer - Tuesday Aug 1, 2017

    A detailed climate model suggests that, as stars brighten, planets get hot fast.

    Source: Ars Technica
  • 2017 Hilton Humanitarian Prize Awarded to icddr,b
    By webmaster@philanthropynewsdigest.org (Kyoko Uchida) - Wednesday Aug 23, 2017

    Formerly known as International Centre for Diarrhoeal Disease Research, Bangladesh, icddr,b was recognized for its work in developing low-cost interventions to address the symptoms of cholera-related diarrhea....

    Source: Philanthropy News Digest (PND)